Biotech Updates

Genome-Edited E3902 Camelina Cleared for Planting in Canada

April 3, 2024

Yield10 Bioscience announced that the Plant Biosafety Office of the Canadian Food Inspection Agency recently reviewed information on the Company's E3902 Camelina sativa (Camelina) and determined that E3902 is not a Plant with Novel Trait and is not subject to a pre-market notification under Part V of the Seeds Regulations.

Yield10's E3902 Camelina combines genome edits in three proprietary genetic traits, C3008a, C3008b, and C3009, that result in an increase in oil production by five percent and produce a lighter seed coat color than the parental Camelina line. E3902 Camelina remains subject to other applicable requirements of the Seeds Act and Regulations in Canada.

Kristi Snell, Chief Science Officer of Yield10 Bioscience said, “We are pleased to see a science-driven framework in Canada for the assessment of new traits engineered into Camelina through genome editing.” She added that the company plans to continue to systematically execute its development and regulatory programs to provide access to new and improved Camelina varieties to growers.

For more details, read the news article in Yield10 Bioscience.

You might also like: